These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6145215)

  • 21. Clinical implications of lower urinary tract pharmacology.
    Whitfield HN
    Urol Res; 1977; 5(2):51-4. PubMed ID: 17938
    [No Abstract]   [Full Text] [Related]  

  • 22. Nepadutant pharmacokinetics and dose-effect relationships as tachykinin NK2 receptor antagonist are altered by intestinal inflammation in rodent models.
    Lecci A; Carini F; Tramontana M; D'Aranno V; Marinoni E; Crea A; Bueno L; Fioramonti J; Criscuoli M; Giuliani S; Maggi CA
    J Pharmacol Exp Ther; 2001 Oct; 299(1):247-54. PubMed ID: 11561086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypotensive and antiaggregative effects of eugenosedin-B with serotonin and alpha/beta-adrenoceptor antagonistic activities in rats and human platelets.
    Shen KP; Chu LW; Hsieh SL; An LM; Chen IJ; Wu BN
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):154-61. PubMed ID: 18287883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
    Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
    Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of antispasmodic drugs on the colonic motility. Part II: Clinical study in man.
    Sasaki D; Kido A; Yoshida Y
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):338-41. PubMed ID: 6147312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of YNS-15P, a new alpha-2 adrenoceptor antagonist, on stress-stimulated colonic propulsion in rats.
    Yamamoto O; Niida H; Tajima K; Shirouchi Y; Kyotani Y; Ueda F; Kise M; Kimura K
    J Pharmacol Exp Ther; 1998 Nov; 287(2):691-6. PubMed ID: 9808698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
    Saslow SB; O'Brien MD; Camilleri M; von der Ohe M; Homburger HA; Klee GG; Pitot HC; Rubin J
    Am J Gastroenterol; 1997 Dec; 92(12):2250-6. PubMed ID: 9399764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitization of rat gastrointestinal tract to acetylcholine and histamine produced by X-radiation.
    Janković SM; Matović M; Milaranović D; Igrutinović I
    Acta Physiol Hung; 1997-1998; 85(3):215-30. PubMed ID: 10101536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substance P activates rat colonic motility via excitatory and inhibitory neural pathways and direct action on muscles.
    Scheurer U; Drack E; Halter F
    J Pharmacol Exp Ther; 1994 Oct; 271(1):7-13. PubMed ID: 7525933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of antispasmodic drugs on colonic motility. Part I: Laboratory study of the dog.
    Sasaki D; Kido A; Yoshida Y
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):333-7. PubMed ID: 6147311
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibition of the motility of human spermatozoa by various pharmacologic agents.
    Peterson RN; Freund M
    Biol Reprod; 1975 Dec; 13(5):552-6. PubMed ID: 1117
    [No Abstract]   [Full Text] [Related]  

  • 32. Peripheral and central administration of exogenous urocortin 1 disrupts the fasted motility pattern of the small intestine in rats via the corticotrophin releasing factor receptor 2 and a cholinergic mechanism.
    Yin Y; Dong L; Yin D
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e79-87. PubMed ID: 17944898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effectiveness of pinaverium bromide therapy on colonic motility disorders in irritable bowel syndrome].
    Wittmann T; Fehér A; Rosztóczy A; Jánosi J
    Orv Hetil; 1999 Feb; 140(9):469-73. PubMed ID: 10204402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Elucidation of the mechanism of nicotinic acid flush in the animal experiment (author's transl)].
    Rohte O; Thormählen D; Ochlich P
    Arzneimittelforschung; 1977; 27(12):2347-52. PubMed ID: 23799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The mechanism of the laxative action of DAN-603 (author's transl)].
    Arch Farmacol Toxicol; 1975 Aug; 1(2):137-46. PubMed ID: 1230028
    [No Abstract]   [Full Text] [Related]  

  • 36. [Role of enkephalins in the neural regulation of colonic motility ].
    Gonella J; Blanquet F; Bouvier M
    Gastroenterol Clin Biol; 1987; 11(3 Pt 2):65B-68B. PubMed ID: 3609629
    [No Abstract]   [Full Text] [Related]  

  • 37. Agents that act luminally to treat diarrhoea and constipation.
    Menees S; Saad R; Chey WD
    Nat Rev Gastroenterol Hepatol; 2012 Nov; 9(11):661-74. PubMed ID: 22945441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacology of the gastrointestinal tract.
    Clark ES; Becht JL
    Vet Clin North Am Equine Pract; 1987 Apr; 3(1):101-22. PubMed ID: 3555722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laxatives and the production of autacoids by rat colon.
    Capasso F; Mascolo N; Autore G; Romano V
    J Pharm Pharmacol; 1986 Aug; 38(8):627-9. PubMed ID: 2876085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Humoral blockade on lethal pulmonary embolism in the awake dog.
    Jacobsen DC; Soden KJ; Allen PD; Daicoff GR
    Surg Forum; 1971; 22():209-11. PubMed ID: 4399269
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.